Fall 2012 MS Connection

Page 6

I will: “The first thing I started to notice as my walking improved with Ampyra was my confidence in my ability to walk to meet my friends.” — Kristie Salerno Kent, diagnosed with MS in 1999.

AMPYRA® (dalfampridine) is indicated as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. Important Safety Information Do not take AMPYRA if you have ever had a seizure or have certain types of kidney problems. The risk of having a seizure is higher in patients with certain types of kidney problems. AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same. AMPYRA may cause serious side effects, including kidney or bladder infections. The most common side effects of AMPYRA include urinary tract infection, trouble sleeping, dizziness, headache, nausea, weakness, back pain, and problems with balance. The majority of side effects reported in the clinical trials were mild and transient. Take AMPYRA exactly as your doctor tells you to take it. Take AMPYRA tablets whole. Do not break, crush, chew or dissolve AMPYRA tablets before swallowing. If you miss a dose of AMPYRA, do not PAID ADVERTISEMENT


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.